NCT00791713View on ClinicalTrials.gov

A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

July 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00791713 - A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER | Biotech Hunter | Biotech Hunter